LISA BEARMAN: Open Payments
NPI 1306492913 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 11 payments from 10 companies in 2025. Trend: 2023 $802 · 2024 $1,460 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $79 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| JAZZ PHARMACEUTICALS INC. | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Radius Health, Inc. | 1 | $27 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| Vifor Pharma, Inc. | 1 | $18 |
| Insmed, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: GLASSIA, Sunosi, DUPIXENT, XYWAV, KEYTRUDA, OPSUMIT, Zemaira, Arikayce.
Industry payments across MD — which companies pay providers there.
